Results 101 to 110 of about 106,214 (290)

Social Representations of Aids and of the Antiretroviral Therapy for People Living with HIV

open access: yesPsicologia, 2008
The aim of this study was to characterize the social representation of Aids and Highly Active Antiretroviral Therapy (HAART) for people living with HIV that have adherence to treatment, users of the public health services of Florianópolis, Santa Catarina.
Tatiana de Lucena Torres   +1 more
doaj  

Assessing the Efficacy of Highly Active Antiretroviral Therapy in the Brain

open access: yesBrain Pathology, 2003
The devastating effects of HIV infection have been documented for the last 2 decades. Since the 1980s over 60 million people have been infected and at present 40 million people globally are living with HIV (72). HIV infects the central nervous system (CNS) early in the disease process.
Kandanearatchi, A   +2 more
openaire   +4 more sources

Public Health Achievements in Rwanda: A 21st Century Transformation

open access: yesPublic Health Challenges, Volume 5, Issue 2, June 2026.
This narrative review examines Rwanda's post‐2000 public health transformation using the WHO health system building blocks. It shows how strategic governance, universal health coverage via mutuelle de santé, community health workers, and digital health tools have driven substantial gains in maternal/child health, infectious disease control, and ...
Niyibizi Julius   +2 more
wiley   +1 more source

Low-Level HIV-I Replication and the Dynamics of the Resting CD4(+) T Cell Reservoir for HIV-I in the Setting of HAART [PDF]

open access: yes, 2008
In the setting of highly active antiretroviral therapy (HAART), plasma levels of human immunodeficiency type-I (HIV-I) rapidly decay to below the limit of detection of standard clinical assays.
Sedaghat, Ahmad R.   +2 more
core   +1 more source

An Outlook on the Impact of HIV Infection and Highly Active Antiretroviral Therapy on the Cardiovascular System – A Review [PDF]

open access: diamond, 2020
Ishan Antony   +5 more
openalex   +1 more source

Value‐based prices of emerging disease‐modifying therapies for Alzheimer's disease in 174 countries: a cost‐effectiveness and threshold analysis

open access: yesAlzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Abstract INTRODUCTION Countries have varying, limited healthcare budgets for emerging disease‐modifying therapies. Cost‐effectiveness analysis, combined with country‐level cost‐effectiveness thresholds, can be used to estimate value‐based prices (VBPs) for lecanemab and donanemab across 174 countries.
Men Thi Hoang   +3 more
wiley   +1 more source

Incidence, clinical presentation, and outcome of HIV-1-associated cryptococcal meningitis during the highly active antiretroviral therapy era: a nationwide cohort study

open access: yesClinical Epidemiology, 2017
Madeleine Touma,1 Line D Rasmussen,2 Raquel Martin-Iguacel,2 Frederik Neess Engsig,3 Nina Breinholt Stærke,4 Mette Stærkind,5 Niels Obel,1 Magnus Glindvad Ahlström1 1Department of Infectious Diseases, Rigshospitalet, Copenhagen ...
Touma M   +7 more
doaj  

Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.

open access: yesPLoS ONE, 2018
BackgroundHuman immunodeficiency virus/Acquired immunodeficiency syndrome associated morbidity and mortality has reduced significantly since the introduction of highly active antiretroviral therapy.
Genet Gebrehiwet Hailu   +4 more
doaj   +1 more source

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1487-1492, May 2026.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart   +7 more
wiley   +1 more source

Features of kidney affection in the conditions of highly active antiretroviral therapy in patients with HIV/AIDS

open access: yesPatologìâ, 2013
As a result of the analysis of 330 archival patient’s cards of patients with HIV/AIDS who received highly active antiretroviral therapy with the inclusion of tenofovir in the treatment scheme, kidney affection has been fixed in 1,5 % of cases only in ...
E.V. Ryabokon   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy